Optimal Contraceptive Choice for Hypertensive Patients with Heavy Bleeding and Anemia

Introduction to Contraceptive Options

The European Society of Cardiology recommends the levonorgestrel-releasing intrauterine system (LNG-IUS) as the safest and most effective contraceptive for women with cardiovascular disease, apart from barrier methods 1, 2, 3
The LNG-IUS reduces menstrual blood loss by 40-90%, improving anemia through decreased bleeding, and provides highly effective contraception safe for hypertensive patients 1, 2

Combined oral contraceptives (OCPs) containing estrogen are contraindicated in women with hypertension due to increased thrombogenic potential and blood pressure elevation risk 1, 2, 4
The CDC recommends avoiding combined hormonal contraceptive methods in women with active cardiovascular conditions 5

The levonorgestrel-containing IUS is specifically recommended to minimize menstrual blood loss in women with iron-deficiency anemia 5
The LNG-IUS increases body iron stores and directly treats the underlying cause of iron-deficiency anemia by dramatically reducing menstrual blood loss 1, 2

Approximately 5% of patients experience vasovagal reactions during IUD insertion, though this is generally well-tolerated in most women with hypertension 1, 2
Blood pressure should be checked at least every 6 months for women using any hormonal contraceptive method, though the LNG-IUS has minimal systemic hormonal effects 4
The European Society of Cardiology and the CDC guidelines support the use of LNG-IUS in hypertensive patients with heavy bleeding and anemia 1, 2, 5